Cargando…
Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
BACKGROUND: The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work found that two adjacent co-occurring mutations R203K and G204R (KR) on the nucleocapsid (N) protein correlate with increased disease...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360309/ https://www.ncbi.nlm.nih.gov/pubmed/37475040 http://dx.doi.org/10.1186/s13073-023-01208-0 |
_version_ | 1785076076248039424 |
---|---|
author | Shuaib, Muhammad Adroub, Sabir Mourier, Tobias Mfarrej, Sara Zhang, Huoming Esau, Luke Alsomali, Afrah Alofi, Fadwa S Ahmad, Adeel Nazir Shamsan, Abbas Khogeer, Asim Hashem, Anwar M. Almontashiri, Naif A. M. Hala, Sharif Pain, Arnab |
author_facet | Shuaib, Muhammad Adroub, Sabir Mourier, Tobias Mfarrej, Sara Zhang, Huoming Esau, Luke Alsomali, Afrah Alofi, Fadwa S Ahmad, Adeel Nazir Shamsan, Abbas Khogeer, Asim Hashem, Anwar M. Almontashiri, Naif A. M. Hala, Sharif Pain, Arnab |
author_sort | Shuaib, Muhammad |
collection | PubMed |
description | BACKGROUND: The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work found that two adjacent co-occurring mutations R203K and G204R (KR) on the nucleocapsid (N) protein correlate with increased disease severity in COVID-19 patients. However, links with the host immune response remain unclear. METHODS: Here, we grouped nasopharyngeal swab samples of COVID-19 patients into two cohorts based on the presence and absence of SARS-CoV-2 nucleocapsid KR mutations. We performed nasopharyngeal transcriptome analysis of age, gender, and ethnicity-matched COVID-19 patients infected with either SARS-CoV-2 with KR mutations in the N protein (KR patients n = 39) or with the wild-type N protein (RG patients n = 39) and compared to healthy controls (n = 34). The impact of KR mutation on immune response was further characterized experimentally by transcriptomic and proteomic profiling of virus-like-particle (VLP) incubated cells. RESULTS: We observed markedly elevated expression of proinflammatory cytokines, chemokines, and interferon-stimulated (ISGs) genes in the KR patients compared to RG patients. Using nasopharyngeal transcriptome data, we found significantly higher levels of neutrophils and neutrophil-to-lymphocyte (NLR) ratio in KR patients than in the RG patients. Furthermore, transcriptomic and proteomic profiling of VLP incubated cells confirmed a similar hyper-inflammatory response mediated by the KR variant. CONCLUSIONS: Our data demonstrate an unforeseen connection between nucleocapsid KR mutations and augmented inflammatory immune response in severe COVID-19 patients. These findings provide insights into how mutations in SARS-CoV-2 modulate host immune output and pathogenesis and may contribute to more efficient therapeutics and vaccine development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-023-01208-0. |
format | Online Article Text |
id | pubmed-10360309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103603092023-07-22 Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity Shuaib, Muhammad Adroub, Sabir Mourier, Tobias Mfarrej, Sara Zhang, Huoming Esau, Luke Alsomali, Afrah Alofi, Fadwa S Ahmad, Adeel Nazir Shamsan, Abbas Khogeer, Asim Hashem, Anwar M. Almontashiri, Naif A. M. Hala, Sharif Pain, Arnab Genome Med Research BACKGROUND: The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work found that two adjacent co-occurring mutations R203K and G204R (KR) on the nucleocapsid (N) protein correlate with increased disease severity in COVID-19 patients. However, links with the host immune response remain unclear. METHODS: Here, we grouped nasopharyngeal swab samples of COVID-19 patients into two cohorts based on the presence and absence of SARS-CoV-2 nucleocapsid KR mutations. We performed nasopharyngeal transcriptome analysis of age, gender, and ethnicity-matched COVID-19 patients infected with either SARS-CoV-2 with KR mutations in the N protein (KR patients n = 39) or with the wild-type N protein (RG patients n = 39) and compared to healthy controls (n = 34). The impact of KR mutation on immune response was further characterized experimentally by transcriptomic and proteomic profiling of virus-like-particle (VLP) incubated cells. RESULTS: We observed markedly elevated expression of proinflammatory cytokines, chemokines, and interferon-stimulated (ISGs) genes in the KR patients compared to RG patients. Using nasopharyngeal transcriptome data, we found significantly higher levels of neutrophils and neutrophil-to-lymphocyte (NLR) ratio in KR patients than in the RG patients. Furthermore, transcriptomic and proteomic profiling of VLP incubated cells confirmed a similar hyper-inflammatory response mediated by the KR variant. CONCLUSIONS: Our data demonstrate an unforeseen connection between nucleocapsid KR mutations and augmented inflammatory immune response in severe COVID-19 patients. These findings provide insights into how mutations in SARS-CoV-2 modulate host immune output and pathogenesis and may contribute to more efficient therapeutics and vaccine development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-023-01208-0. BioMed Central 2023-07-21 /pmc/articles/PMC10360309/ /pubmed/37475040 http://dx.doi.org/10.1186/s13073-023-01208-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Shuaib, Muhammad Adroub, Sabir Mourier, Tobias Mfarrej, Sara Zhang, Huoming Esau, Luke Alsomali, Afrah Alofi, Fadwa S Ahmad, Adeel Nazir Shamsan, Abbas Khogeer, Asim Hashem, Anwar M. Almontashiri, Naif A. M. Hala, Sharif Pain, Arnab Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
title | Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
title_full | Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
title_fullStr | Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
title_full_unstemmed | Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
title_short | Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
title_sort | impact of the sars-cov-2 nucleocapsid 203k/204r mutations on the inflammatory immune response in covid-19 severity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360309/ https://www.ncbi.nlm.nih.gov/pubmed/37475040 http://dx.doi.org/10.1186/s13073-023-01208-0 |
work_keys_str_mv | AT shuaibmuhammad impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT adroubsabir impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT mouriertobias impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT mfarrejsara impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT zhanghuoming impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT esauluke impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT alsomaliafrah impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT alofifadwas impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT ahmadadeelnazir impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT shamsanabbas impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT khogeerasim impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT hashemanwarm impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT almontashirinaifam impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT halasharif impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity AT painarnab impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity |